Lohmann Therapie-Systeme
Benjamin Schinor has held various roles throughout their work experience. Benjamin started their career as a PhD student and scientific researcher at the University of Muenster in 2008. After completing their PhD, they joined UKM Uniklinikum Muenster as a postdoctoral researcher from November 2013 to August 2014. In 2014, they transitioned to LTS Lohmann Therapie-Systeme AG, where they initially worked as a scientist until April 2020. Benjamin then assumed the role of Director and Head of Laboratory, a position they currently hold.
Benjamin Schinor attained their first degree, a Diplom in Organische Chemie, from the University of Münster in 2008. Later, they pursued further academic achievements and completed their Dr. rer nat/PhD degree in Organische Chemie from the same university, concluding their education in 2013.
This person is not in any offices
Lohmann Therapie-Systeme
LTS is the market leader in transdermal therapeutic systems and oral thin films. We develop and manufacture innovative drug delivery systems that offer the patient reliable therapeutic efficacy with the highest level of convenience and comfort – the benefits of which have already proven themselves on the global markets.